Association of abnormal carbon dioxide levels with poor neurological outcomes in aneurysmal subarachnoid hemorrhage: a retrospective observational study

异常二氧化碳水平与动脉瘤性蛛网膜下腔出血患者不良神经系统预后之间的关联:一项回顾性观察研究

阅读:1

Abstract

BACKGROUND: In patients with aneurysmal subarachnoid hemorrhage (SAH), an association between hypocapnia and poor clinical outcomes has been reported. However, the optimal arterial carbon dioxide tension (PaCO(2)) remains unknown. The present retrospective study aimed to examine the association of abnormal PaCO(2) levels with neurological outcomes and investigate the optimal target PaCO(2) level in patients with SAH. METHODS: We retrospectively selected consecutive adult patients hospitalized in the intensive care unit (ICU) for SAH between January 2009 and April 2017. Univariate and multivariate analyses were performed to identify the independent predictors of unfavorable neurological outcomes (i.e., modified Rankin scale score of 3-6 on hospital discharge). RESULTS: Among 158 patients with SAH, 73 had unfavorable neurological outcomes. During the first 2 weeks in the ICU, the median number of PaCO(2) measurements per patient was 43. The factors significantly associated with unfavorable neurological outcomes were age, Hunt and Kosnik grade, maximum lactate levels during the first 24 h, and maximum (odds ratio [OR], 1.12; 95% confidence interval [CI], 1.03-1.21; p < 0.01) and minimum PaCO(2) levels (OR, 0.81; 95% CI, 0.72-0.92; p < 0.01). Receiver operating characteristic curve analysis revealed that the cutoff range of PaCO(2) was 30.2-48.3 mmHg. Unfavorable neurological outcomes were noted in 78.8% of patients with PaCO(2) levels outside this range and in 22.8% of patients with PaCO(2) levels within this range. CONCLUSIONS: Both the maximum and minimum PaCO(2) levels during ICU management in patients with SAH were significantly associated with unfavorable neurological outcomes. Further prospective studies are required to validate our findings and explore their clinical implications. Our findings may provide a scientific rationale for these future prospective studies.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。